ZYME - Zymeworks BC Inc
IEX Last Trade
11.73
0.010 0.085%
Share volume: 375,073
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$11.72
0.01
0.09%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | |
---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | |
Report Date | 2022-05-04 | 2022-08-04 | |
Total revenue | 1.916 M | 5.442 M | |
Cost of revenue | 0.000 | 0.000 | |
Gross profit | 1.916 M | 5.442 M | |
184.03% | |||
Operating expenses | 74.602 M | 71.265 M | |
Selling general and admin | 12.092 M | 15.243 M | |
Research and development | 62.510 M | 56.022 M | |
Total expenses | 74.602 M | 71.265 M | |
-4.47% | |||
Operating income | -72.686 M | -65.823 M | |
Ebit | -72.686 M | -65.823 M | |
Pretax income | -72.699 M | -64.628 M | |
-11.10% | |||
Income tax | -74.000 K | -9.000 K | |
Net income basic | -72.625 M | -64.619 M | |
11.02% | |||
Net income | -72.625 M | -64.619 M | |
11.02% |